Table 2.
Variable | No. | Total patients | p-valuea) | Suprasellar | p-valuea) | Pineal gland | p-valuea) | Basal ganglia | p-valuea) | Bifocal | p-valuea) | One-way ANOVA |
Post hoc comparison | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
df | p-value | |||||||||||||
FIQ | 34 | 96.74±21.36 | 0.379 | 110.50±17.98 | 0.143 | 92.70±25.60 | 0.391 | 76.83±8.66 | 0.001 | 101.70±15.69 | 0.740 | 3,30 | 0.016 | BG < suprasellar |
VIQ | 33 | 101.36±19.13 | 0.685 | 112.00±20.84 | 0.178 | 99.80±18.78 | 0.974 | 83.33±10.52 | 0.012 | 106.30±16.21 | 0.250 | 3,29 | 0.033 | BG < suprasellar |
PIQ | 33 | 91.55±22.80 | 0.041 | 107.57±14.67 | 0.221 | 86.10±36.46 | 0.183 | 73.83±10.82 | 0.002 | 96.40±15.59 | 0.484 | 3,29 | 0.035 | BG < suprasellar |
VC | 29 | 102.17±18.72 | 0.537 | 112.25±16.74 | 0.077 | 96.63±20.56 | 0.657 | 83.80±13.24 | 0.052 | 109.13±12.30 | 0.074 | 3,25 | 0.020 | BG < suprasellar |
PO | 29 | 96.83±21.48 | 0.433 | 110.25±17.54 | 0.142 | 87.25±27.44 | 0.230 | 82.00±11.38 | 0.024 | 102.25±14.45 | 0.673 | 3,25 | 0.044 | BG, pineal < suprasellar |
FD | 28 | 99.39±19.35 | 0.869 | 102.86±17.06 | 0.673 | 102.88±26.51 | 0.768 | 84.40±7.47 | 0.010 | 102.25±16.26 | 0.707 | 3,24 | 0.312 | - |
PS | 29 | 86.59±24.61 | 0.007 | 104.88±14.95 | 0.387 | 82.63±25.48 | 0.095 | 67.00±17.85 | 0.014 | 84.50±26.24 | 0.139 | 3,25 | 0.039 | BG < suprasellar |
MQ | 32 | 84.75±19.35 | 0.000 | 86.50±23.85 | 0.153 | 90.78±16.13 | 0.125 | 81.50±16.51 | 0.041 | 79.33±20.92 | 0.018 | 3,28 | 0.633 | - |
EIQ | 23 | 84.52±26.18 | 0.010 | 86.83±19.93 | 0.167 | 104.14±14.65 | 0.482 | 60.60±24.80 | 0.024 | 78.20±29.82 | 0.177 | 3,19 | 0.024 | BG < pineal |
Values are presented as mean±standard deviation. FIQ, full-scale intelligence quotient (IQ); BG, basal ganglia; VIQ, verbal IQ; PIQ, performance IQ; VC, verbal comprehension; PO, perceptional organization; FD, freedom of distractibility; PS, processing speed; MQ, memory quotient; EIQ, executive IQ.
Comparison with normal population.